Veru Inc (NASDAQ:VERU) Director Harry Fisch bought 10,000 shares of the business’s stock in a transaction that occurred on Friday, March 9th. The stock was acquired at an average cost of $1.88 per share, for a total transaction of $18,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Harry Fisch also recently made the following trade(s):
- On Wednesday, March 7th, Harry Fisch bought 24,000 shares of Veru stock. The stock was acquired at an average cost of $1.62 per share, for a total transaction of $38,880.00.
Veru Inc (NASDAQ:VERU) traded down $0.01 during midday trading on Friday, hitting $1.82. The company had a trading volume of 166,682 shares, compared to its average volume of 97,178. The company has a market capitalization of $97.39, a PE ratio of -6.74 and a beta of 0.96. Veru Inc has a 12 month low of $0.90 and a 12 month high of $3.00.
Several analysts recently issued reports on the company. Zacks Investment Research raised Veru from a “sell” rating to a “hold” rating in a research note on Wednesday. HC Wainwright set a $5.00 target price on Veru and gave the stock a “buy” rating in a research note on Tuesday, March 6th. Finally, ValuEngine raised Veru from a “sell” rating to a “hold” rating in a research note on Thursday, March 1st.
Veru Inc, formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.
Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.